Muzinich & Co.
Credit manager founded in New York in 1988, with its European headquarters in London, lending senior and unitranche debt to lower-mid-market companies from its private debt funds and alongside banks.
Considering finance for your business? Discuss the lender options.
No published facility band. The field is where the other 59 private-credit and direct-lending funds publish theirs.
| Lender | Published band |
|---|---|
| Muzinich & Co. | no published band |
| The other private-credit and direct-lending funds | 29 of 59 publish a band; at the field's peak 24 of them cover the same facility size |
| The band this directory reads for | £3m to £15m |
The shaded field is the other 59 private-credit and direct-lending funds in this directory, taller where more of them publish a band covering that size.
What they do
Muzinich & Co. was founded in New York in 1988, began managing high yield bonds in 1990 and opened its European headquarters in London in 1999. It describes itself as privately owned and as a manager of corporate credit only, across public markets and a private markets platform covering private debt, parallel lending, capital solutions and aviation finance. Private debt began with country strategies in Italy and Iberia in 2014, followed by UK and French strategies in 2015 and the pan-European platform in 2017. That platform manages about US$5.5bn within a firm-wide total near US$36bn and lends committed fund capital rather than deposits. The flagship funds write senior secured and unitranche loans to lower-mid-market companies, sponsor-backed and founder-owned, with second lien, mezzanine and minority equity co-investment available beside them. Pan-European Private Debt III, the third fund, targets 25 to 35 senior secured loans of €15m to €50m across eight to ten countries. An evergreen parallel lending strategy co-originates senior loans with local and international banks, and a European Private Credit ELTIF opens the asset class to retail investors. The UK team lends from London and Manchester, and Muzinich & Co. Limited is authorised and regulated by the FCA under registration number 19226.
Who they lend to
The private debt funds look for non-distressed lower-mid-market companies with solid balance sheets, often family or founder-owned, raising capital for expansion or an acquisition. The published European range is EBITDA of €5m to €25m, about £4.3m at the floor, while the UK fund backed by the British Business Bank in 2016 was framed at £3m to £20m. Sponsored and sponsorless deals are both in scope, and sponsorless lower-mid-market lending is a stated focus. Named sectors are healthcare, business services, software and technology, food production and specialty consumer, professional services and education. UK lending is national, with the Manchester office there to reach companies outside London and the South East. Parallel lending reaches relatively low-levered European companies: banks introduced about two-thirds of the opportunities that strategy screened, and sponsors and advisers the remaining third.
How they structure a facility
Muzinich & Co. can finance across the capital structure: first-lien senior, unitranche and stretched senior, second lien and mezzanine, with minority equity co-investment alongside the debt. Lending is bilateral and direct. Senior facilities are secured, typically by a debenture and share pledge, and the funds will also take a junior position. The private debt funds publish no leverage limit, tenor, amortisation profile or margin, and state no position on personal guarantees. Its commentary argues that lower-mid-market loans keep more maintenance covenants and stronger protection than large-cap unitranche. The parallel lending strategy publishes portfolio figures rather than terms: mainly senior secured loans, average borrower leverage of about 3.5x EBITDA and EBITDA above 4x the cost of debt, with scheduled term-loan amortisation on many deals. Amortisation and prepayments there return about 15% to 20% of gross asset value a year. The firm's pricing thesis is that the lower-mid-market keeps higher relative spreads than large-cap lending, with fund pricing above bank senior.
Published terms
- Pricing
- Lower-mid-market retains higher relative spreads than large-cap (their thesis); fund pricing above bank senior; 2024 syndicated reopening pressured pricing
- Published by 1 of 60
- Speed to terms
- Not published
- Published by 8 of 60
- EBITDA floor
- From about £4.3m (€5m published)
- Published by 17 of 60
- Sponsored or sponsorless
- Both - explicitly provides finance in both sponsored and sponsorless deals; sponsorless lower-mid-market is a stated focus
- Where they lend
- UK-wide; Manchester office targets industrial heartland outside London/SE, plus London desk
- How they decide
- Pan-European private-debt platform with UK desk; investment-committee model; origination/execution/monitoring run by UK team
- Covenants
- A loose covenant package
- Published by 15 of 60
- Leverage
- Not published for the private debt funds; the parallel lending portfolio averages about 3.5x EBITDA, with EBITDA above 4x the cost of debt
- Published by 6 of 60
As published by the lender and last reviewed October 2026. Terms quoted on a deal are set by the credit, not by a published band.
How a deal reaches them
Private debt deals reach Muzinich & Co. through private equity sponsors and corporate finance advisers, and a founder-owned company without a sponsor is a stated part of the market it serves. The UK team runs origination, execution and monitoring from London and Manchester, and credit decisions go to an investment committee on the pan-European platform. No turnaround time is published. Parallel lending is a second route, run with partner banks: a bank originates the loan, stays invested and shares part of the exposure with the strategy. By 31 August 2026 that platform had screened about 1,400 opportunities and turned down around 85%, and the firm says it underwrites each borrower independently of the bank. It describes itself as the only independent asset manager with a broad parallel lending presence in Europe.
Where they fit in a lower-mid-market raise
Muzinich & Co. is the natural call for a UK company raising near the upper end of £3m to £15m, with EBITDA from about £4.3m, a resilient sector and an expansion or acquisition plan. The main fund's disclosed tickets start at €15m, so only the largest raises in the band reach it. It will write that cheque with or without a sponsor, and its UK record covers sponsor-backed deals and management buyouts alike. A Manchester office means a company outside London is not at a disadvantage. Within its category it sits between the larger pan-European platforms such as Arcmont, Ares and Barings, whose core tickets start higher, and lower-mid-market unitranche lenders such as Beechbrook, Kartesia and Cordet, which reach further down. Parallel lending adds a different fit: a low-levered company whose bank wants to keep the relationship while sharing the credit exposure with an institutional lender.
Where they are not the fit
Below €15m of debt, a deal sits under the main fund's disclosed tickets, and neither the parallel lending strategy nor the ELTIF publishes a minimum. EBITDA under about £3m falls outside the stated UK focus, and the €5m European floor sets the bar higher still. The private debt funds want non-distressed companies with solid balance sheets; a good business in temporary difficulty falls to a separate capital solutions platform instead. Manufacturing and other asset-heavy or cyclical borrowers are not among the named sectors. A borrower wanting a relationship bank, with a current account and day-to-day facilities, will not find one here.
What rules a deal out
Stated limits, taken from Muzinich & Co.’s own published criteria. A limit is where a lender starts from, not where it always ends: several of these move on a strong enough credit.
- Private debt funds target non-distressed companies with solid balance sheets
- Main fund loans start at €15m
- Published EBITDA range starts at €5m, about £4.3m
How they sit against the category
- Like 59 of the 60, it publishes no indicative price; a margin comes from a conversation, not a page.
Counted across the 60 private-credit & direct-lending funds in this directory, on what each one publishes. What a lender discloses and what it will do are different things.
Recent activity on the public record
In January 2024, AFO Group joined the disclosed UK portfolio, followed by Bullen Healthcare in September 2024. In 2025, Muzinich & Co. formed a strategic partnership with SMBC to launch a European loan origination joint venture, and launched an ELTIF 2.0 private credit strategy. Its European Private Credit ELTIF held €194m at 31 December 2025, across 14 investments in eight geographies. In May 2026, Science in Sport Group was added to the UK portfolio. In June 2026, the firm raised more than €1.3bn for Pan-European Private Debt III, against €706m and €800m for the two funds before it, and took the European small-cap prize at the Debtwire Direct Lending Awards. In October 2026, it reported its evergreen parallel lending portfolio at more than 160 companies, with average borrower leverage of about 3.5x.
8 dated items, 2024 to 2026, numbered as listed below.
| No. | Date | Item |
|---|---|---|
| 01 | Sep 2024 | Bullen Healthcare added to the disclosed UK private debt portfolio. |
| 02 | Dec 2024 | Set out its parallel lending model, co-originating with more than 50 European banks. |
| 03 | 2025 | Established a strategic partnership with SMBC to launch a European loan origination joint venture, and launched an ELTIF 2.0 private credit strategy. |
| 04 | Dec 2025 | The European Private Credit ELTIF held €194m across 14 investments in eight geographies. |
| 05 | May 2026 | Science in Sport Group added to the disclosed UK private debt portfolio. |
| 06 | Jun 2026 | Named European Small-Cap Direct Lending Manager of the Year at the Debtwire Direct Lending Awards 2026. |
| 07 | Jun 2026 | Raised more than €1.3bn for Pan-European Private Debt III, its largest European private credit vehicle, against €706m and €800m for the two funds before it. |
| 08 | Oct 2026 | Reported its evergreen parallel lending strategy at more than 160 companies, with average borrower leverage of about 3.5x EBITDA at 31 August 2026. |
On the record
September 2024: Bullen Healthcare added to the disclosed UK private debt portfolio.
December 2024: Set out its parallel lending model, co-originating with more than 50 European banks.
2025: Established a strategic partnership with SMBC to launch a European loan origination joint venture, and launched an ELTIF 2.0 private credit strategy.
December 2025: The European Private Credit ELTIF held €194m across 14 investments in eight geographies.
May 2026: Science in Sport Group added to the disclosed UK private debt portfolio.
June 2026: Raised more than €1.3bn for Pan-European Private Debt III, its largest European private credit vehicle, against €706m and €800m for the two funds before it.
June 2026: Named European Small-Cap Direct Lending Manager of the Year at the Debtwire Direct Lending Awards 2026.
October 2026: Reported its evergreen parallel lending strategy at more than 160 companies, with average borrower leverage of about 3.5x EBITDA at 31 August 2026.
Muzinich & Co. Limited is authorised and regulated by the FCA with firm reference number 19226, incorporated in England and Wales under company number 03852444, registered office at 8 Hanover Street, London W1S 1YQ.
Muzinich's pan-European private debt platform was established in 2014 and manages approximately US$5.5bn AUM within a total firm AUM of approximately US$36bn.
Questions this page answers
Who owns Muzinich & Co.?
Muzinich & Co. describes itself as privately owned and says private ownership fosters a focus on long-term returns and partnerships. Its UK company, Muzinich & Co. Limited, is incorporated in England and Wales under company number 03852444 and authorised and regulated by the FCA, registration number 19226.
As published at muzinich.com
Does Muzinich & Co. lend to a company going through a difficult patch?
Not through its private debt funds, which target non-distressed companies. Muzinich & Co. runs a separate capital solutions platform that it says provides flexible financing solutions to good companies facing temporary difficulties.
As published at muzinich.com
How does Muzinich & Co.'s parallel lending work?
Muzinich & Co. co-originates loans with local and international banks, which keep part of the loan and share the rest with its strategy. Banks brought about two-thirds of the roughly 1,400 opportunities screened by 31 August 2026, sponsors and advisers the other third, and it turned down around 85% of them.
As published at muzinich.com
How much leverage will Muzinich & Co. lend at?
Muzinich & Co. publishes no leverage limit for its private debt funds. In its evergreen parallel lending strategy, average borrower leverage has been about 3.5x EBITDA, with EBITDA above 4x the cost of debt, across more than 160 companies, mainly through senior secured loans.
As published at muzinich.com
Does Muzinich & Co. lend outside the UK?
Yes. Muzinich & Co. says its private debt business provides financing to small and medium-sized companies in Europe, Asia and the US, from 18 offices globally, and its parallel lending strategy finances European lower middle-market companies alongside banks.
As published at muzinich.com
How long has Muzinich & Co. been lending to companies?
Muzinich & Co. was founded in New York in 1988 and started managing high yield bonds in 1990. Its first private debt strategies, in Italy and Iberia, launched in 2014, the UK and French strategies in 2015 and the pan-European private debt platform in 2017.
As published at muzinich.com
Where are Muzinich & Co.'s parallel lending portfolio managers based?
Muzinich & Co. lists Dublin, London, Madrid, Milan, Paris and Frankfurt as the portfolio manager locations for its parallel lending strategy, which it says co-originates loans with local and international banks to complement their normal lending.
As published at muzinich.com
Does Muzinich & Co. lend to companies without a private-equity sponsor?
Yes. Muzinich & Co. lends to owner-managed and sponsor-backed borrowers alike, so a company with no private-equity backer is not out of scope on that ground.
Sources: muzinich.com · muzinichprivatedebt.com · Companies House
Terms used on this page: Unitranche · Sponsor · Mezzanine · Amortisation · Debenture
This profile is a curated reference note drawn from public sources, not financial advice or a recommendation. Appetite and terms change; a lender's fit for a given credit is established by approaching it, not inferred from a page.